Emerging Prognostic Groups Across the Spectrum of Metastatic Castration-Sensitive Prostate Cancer: Disease Outcomes and Genomics

被引:0
|
作者
Sutera, P. [1 ]
Van der Eecken, K. [2 ]
Kishan, A. U. [3 ]
Hamid, A. [4 ]
Grist, E. [5 ]
Attard, G. [6 ]
Lotan, T. L. [7 ]
Mendes, A. [1 ]
Sweeney, C. [8 ]
Paller, C. [9 ]
Carducci, M. [9 ]
Ross, A. E. [10 ]
Pienta, K. [11 ]
Feng, F. Y. [12 ]
Eisenberger, M. [9 ]
Antonarakis, E. S. [9 ]
Ost, P. [13 ]
Tran, P. T. [11 ]
Deek, M. P. [9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Ghent, Ghent, Belgium
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Inst Canc Res Royal Marsden, London, England
[6] Inst Canc Res, London, England
[7] Johns Hopkins Sch Med, Dept Pathol & Oncol, Baltimore, MD USA
[8] Dana Farber Inst, Boston, MA USA
[9] Johns Hopkins Med, Baltimore, MD USA
[10] Northwestern Univ, Chicago, IL 60611 USA
[11] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2596
引用
收藏
页码:E294 / E295
页数:2
相关论文
共 50 条
  • [21] Transcriptomic Heterogeneity of Metastatic Disease Timing within Metastatic Castration-Sensitive Prostate Cancer
    Sutera, P.
    Shetty, A.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Fonteyne, V.
    Verbeke, S.
    Song, D.
    Ross, A. E.
    Feng, F. Y.
    Gillessen, S.
    Attard, G.
    James, N.
    Lotan, T. L.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E261 - E262
  • [22] Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
    del Castillo-Acuna, Rocio
    Serradilla, Ana
    Lopez-Campos, Fernando
    Counago, Felipe
    ARCHIVOS DE BRONCONEUMOLOGIA, 2024, 60 (08): : 537 - 538
  • [23] Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive for Prostate Cancer
    Stopsack, Konrad H.
    Nandakumar, Subhiksha
    Wibmer, Andreas G.
    Haywood, Samuel
    Weg, Emily S.
    Barnett, Ethan S.
    Kim, Chloe J.
    Carbone, Emily A.
    Vasselman, Samantha E.
    Nguyen, Bastien
    Hullings, Melanie A.
    Scher, Howard I.
    Morris, Michael J.
    Solit, David B.
    Schultz, Nikolaus
    Kantoff, Philip W.
    Abida, Wassim
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3230 - 3238
  • [24] How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Ionescu, Filip
    Zhang, Jingsong
    CANCER CONTROL, 2024, 31
  • [25] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Fizazi, Karim
    NamPhuong Tran
    Fein, Luis
    Matsubara, Nobuaki
    Rodriguez-Antolin, Alfredo
    Alekseev, Boris Y.
    Ozguroglu, Mustafa
    Ye, Dingwei
    Feyerabend, Susan
    Protheroe, Andrew
    De Porre, Peter
    Kheoh, Thian
    Park, Youn C.
    Todd, Mary B.
    Chi, Kim N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 352 - 360
  • [26] Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting
    Morgans, Alicia K.
    Stockler, Martin R.
    EUROPEAN UROLOGY FOCUS, 2019, 5 (02): : 144 - 146
  • [27] Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer
    Sutera, P. A.
    Shetty, A. C.
    Hakansson, A.
    Van der Eecken, K.
    Song, Y.
    Liu, Y.
    Chang, J.
    Fonteyne, V.
    Mendes, A. A.
    Lumen, N.
    Delrue, L.
    Verbeke, S.
    De Man, K.
    Rana, Z.
    Hodges, T.
    Hamid, A.
    Roberts, N.
    Song, D. Y.
    Pienta, K.
    Ross, A. E.
    Feng, F.
    Joniau, S.
    Spratt, D.
    Gillessen, S.
    Attard, G.
    James, N. D.
    Lotan, T.
    Davicioni, E.
    Sweeney, C.
    Tran, P. T.
    Deek, M. P.
    Ost, P.
    ANNALS OF ONCOLOGY, 2023, 34 (07) : 605 - 614
  • [28] Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!
    Messina, Carlo
    Messina, Marco
    Boccardo, Francesco
    EUROPEAN UROLOGY, 2018, 73 (01) : 147 - 148
  • [29] Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
    Singh, Kirti
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (02) : 171 - 172
  • [30] Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
    George, Daniel J.
    Agarwal, Neeraj
    Ramaswamy, Krishnan
    Klaassen, Zachary
    Bitting, Rhonda L.
    Russell, David
    Sandin, Rickard
    Emir, Birol
    Yang, Hongbo
    Song, Wei
    Lin, Yilu
    Hong, Agnes
    Gao, Wei
    Freedland, Stephen J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (04) : 765 - 775